XKRX
089980
Market cap186mUSD
Dec 05, Last price
17,660.00KRW
1D
1.79%
1Q
0.51%
Jan 2017
95.57%
IPO
160.47%
Name
Sang-A Frontec Co Ltd
Chart & Performance
P/E
44.68
P/S
1.60
EPS
395.28
Div Yield, %
—
Shrs. gr., 5y
2.34%
Rev. gr., 5y
-1.60%
Revenues
171.75b
-6.45%
Net income
6.16b
-48.62%
CFO
21.63b
-24.56%
Dividend
Dec 27, 2023200 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sang-A Frontec Co.,Ltd. engages in the research and development, production, and sale of materials/parts based on engineering plastics in South Korea and internationally. The company offers fuel cells; membranes, including vent filters and ePTFE for textiles, as well as membranes for medical use; semiconductor products, such as jar boxes, solar cassettes, FOUP products, wafer carriers, storage boxes, PFA/FEP tubes, and mold release films; medium and large, cylindrical, and small type batteries; and display products comprising cell cassettes, ACF bonding sheets, support bars, and FPD cassettes. It also provides automotive products consisting of air vents, and PTFE tubes and rings; OA products that include wireless charging kits, laser printer/MFP/copy machines, metal sleeves, fuser films, fuser and transfer belts, and guide claws; SG and LX sheet, and backup board PCBs; and medical devices, such as safety filter syringes, epidural needle kits, Green Medi green VACs, and filter needle syringes. The company was founded in 1974 and is headquartered in Incheon, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||